1. PSAT1 Regulated Oxidation-Reduction Balance Affects the Growth and Prognosis of Epithelial Ovarian Cancer


    Yiqun Zhang et al, 2020, OncoTargets and Therapy CrossRef
  2. Phosphoserine Aminotransferase 1: A Metabolic Enzyme Target of Cancers
    Yuping Chen et al, 2023, Current Cancer Drug Targets CrossRef
  3. miRNA-195-5p/PSAT1 feedback loop in human triple-negative breast cancer cells
    Huiling Wang et al, 2023, Genes & Genomics CrossRef
  4. An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy
    Mingtao Feng et al, 2022, Frontiers in Genetics CrossRef
  5. Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy
    Jing Zhang et al, 2023, Frontiers in Oncology CrossRef
  6. The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment
    Xijia Zhou et al, 2023, Frontiers in Genetics CrossRef
  7. Ferroptosis-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Diffuse Large B-Cell Lymphoma
    Huan Chen et al, 2021, Pharmacogenomics and Personalized Medicine CrossRef
  8. Development of Novel Cancer Biomarkers for Diagnosis and Prognosis
    Kholood Abid Janjua et al, 2022, Cancer Biomarkers in Diagnosis and Therapeutics CrossRef
  9. Therapeutic potential of targeting HSPA5 through dual regulation of two candidate prognostic biomarkers ANXA1 and PSAT1 in osteosarcoma
    Xiaojun Tang et al, 2021, Aging CrossRef